Opposite roles of STAT and PPARγ in the induction of p21 WAF1 expression by IL-13 in human peripheral blood monocytes

European Cytokine Network

Volumn 19, Issue 4, 2008, Pages 156-165

  Dubourdeau, Marc ^a,b   Chêne, Gérald ^a   Coste, Agnés ^a   Bernad, José ^a   Lepert, Jean Claude ^a   Orfila, Claudine ^a   Pipy, Bernard ^a   Rousseau, Denis ^c  

^a CHU RANGUEIL   (France)

^b Ambiotis SAS   (France)

^c CEA GRENOBLE   (France)

Author keywords

Arachidonic acid metabolism; Nuclear receptors; Prostaglandin j2; Th2 cytokines

Indexed keywords

ARACHIDONIC ACID; CYCLIN DEPENDENT KINASE INHIBITOR 1; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR ALPHA1; INTERLEUKIN 4 RECEPTOR ALPHA; JANUS KINASE 2; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STAT PROTEIN; TYROSINE; 15 DEOXYPROSTAGLANDIN J2; 15-DEOXYPROSTAGLANDIN J2; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DRUG DERIVATIVE; PROSTAGLANDIN D2; PROTEIN KINASE INHIBITOR;

ARACHIDONIC ACID METABOLISM; ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE ACTIVATION; HUMAN; HUMAN CELL; MONOCYTE; PLASMID; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; ENZYME SPECIFICITY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM;

CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HUMANS; INTERLEUKIN-13; MONOCYTES; PPAR GAMMA; PROSTAGLANDIN D2; PROTEIN KINASE INHIBITORS; STAT TRANSCRIPTION FACTORS; SUBSTRATE SPECIFICITY; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 64049083413     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2008.0134     Document Type: Article

References (64)

1. Grage-Griebenow E, Flad HD, Ernst M. Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol 2001; 69: 11-20.
2. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767-811.
3. McKenzie AN, Culpepper JA, de Waal Malefyt R, Brière F, Pun- nonen J, Aversa G, et al. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 1993; 90: 3735-9.
4. Hart PH, Bonder CS, Balogh J, Dickensheets HL, Donnelly RP, Finlay-Jones JJ. Differential responses of human monocytes and macrophages to IL-4 and IL-13. J Leukoc Biol 1999; 66: 575-8.
5. Minty A, Chalon P, Derocq JM, Dumont X, Guillemot JC, Kaghad M, et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362: 248-50.
6. Sozzani P, Cambon C, Vita N, Seguelas MH, Caput D, Ferrara P, et al. Interleukin-13 inhibits protein kinase C-triggered respiratory burst in human monocytes. Role of calcium and cyclic AMP. J Biol Chem 1995; 270: 5084-8.
7. Zurawski SM, Chomarat P, Djossou O, Bidaud C, McKenzie AN, Miossec P, et al. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J Biol Chem 1995; 270: 13869-78.
8. Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS, Leonard WJ. cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J Biol Chem 1996; 271: 29265-70.
9. Miloux B, Laurent P, Bonnin O, Lupker J, Caput D, Vita N, Fer- rara P. Cloning of the human IL-13R alpha1 chain and reconstitu- tion with the IL4R alpha of a functional IL-4/IL-13 receptor complex. FEBS Lett 1997; 401: 163-6.
10. Doyle AG, Herbein G, Montaner LJ, Minty AJ, Caput D, Ferrara P, et al. Interleukin-13 alters the activation state of murine macro- phages in vitro: comparison with interleukin-4 and interferon- gamma. Eur JImmunol 1994; 24: 1441-5.
11. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1994; 176: 287-92.
12. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35.
13. Mosser DM. The many faces of macrophage activation. J Leukoc Biol 2003; 73: 209-12.
14. Kelly-Welch AE, Hanson EM, Boothby MR, Keegan AD. Interleukin-4 and interleukin-13 signaling connections maps. Science 2003; 300: 1527-8.
15. Huang JT, Welch JS, Ricote M, Binder CJ, Willson TM, Kelly C, et al. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 1999; 400: 378-82.
16. Huang JT, Welch JS, Ricote M, Binder CJ, Willson TM, Kelly C, et al. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 1999; 400: 378-82.
17. Ricote M, Welch JS, Glass CK. Regulation of macrophage gene expression by the peroxisome proliferator-activated receptor- gamma. Horm Res 2000; 54: 275-80.
18. Feng J, Han J, Pearce SF, Silverstein RL, Gotto Jr. AM, Hajjar DP, et al. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J Lipid Res 2000; 41: 688-96.
19. Coste A, Dubourdeau M, Linas MD, Cassaing S, Lepert JC, Balard P, et al. PPARγamma promotes mannose receptor gene expression in murine macrophages and contributes to the induction of this receptor by IL-13. Immunity 2003; 19: 329-39.
20. Egan BS, Abdolrasulnia R, Shepherd VL. IL-4 modulates tran- scriptional control of the mannose receptor in mouse FSDC dendritic cells. Arch Biochem Biophys 2004; 428: 119-30.
21. Li M, Pascual G, Glass CK. Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene. Mol Cell Biol 2000; 20: 4699-707.
22. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxi- some proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998; 391: 79-82.
23. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998; 391: 82-6.
24. Li AC, Brown KK, Silvestre MJ, Willson TM, Palinski W, Glass CK. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest 2000; 106: 523-31.
25. Chung SW, Kang BY, Kim SH, Pak YK, Cho D, Trinchieri G, et al. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B. J Biol Chem 2000; 275: 32681-7.
26. Klappacher GW, Glass CK. Roles of peroxisome proliferator- activated receptor gamma in lipid homeostasis and inflammatory responses of macrophages. Curr Opin Lipidol 2002; 13: 305-12.
27. Welch JS, Ricote M, Akiyama TE, Gonzalez FJ, Glass CK. PPARγamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macro- phages. Proc Natl Acad Sci USA 2003; 100: 6712-7.
28. Wagner EF, Hleb M, Hanna N, Sharma S. A pivotal role of cyclin D3 and cyclin-dependent kinase inhibitor p27 in the regulation of IL-2-, IL-4-, or IL-10-mediated human B cell proliferation. J Im-munol 1998; 161: 1123-31.
29. Kaplan MH, Daniel C, Schindler U, Grusby MJ. Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression. Mol Cell Biol 1998; 18: 1996-2003.
30. Zhang S, Lawless VA, Kaplan MH. Cytokine-stimulated T lymphocyte proliferation is regulated by p27Kip1. J Immunol 2000; 165: 6270-7.
31. Blanchard DA, Affredou MT, Vazquez A. Modulation of the p27kip1 cyclin-dependent kinase inhibitor expression during IL- 4-mediated human B cell activation. J Immunol 1997; 158: 3054-61.
32. WAF1 and IRF-1. Exp Mol Med 2004; 36: 372-9.
33. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13: 1501-12.
34. Xaus J, Comalada M, Valledor AF, Cardo M, Herrero C, Soler C, et al. Molecular mechanisms involved in macrophage survival, proliferation, activation or apoptosis. Immunobiology 2001; 204: 543-50.
35. Kramer JL, Baltathakis I, Alcantara OS, Boldt DH. Differentiation of functional dendritic cells and macrophages from human peripheral blood monocyte precursors is dependent on expression of p21 (WAF1/CIP1) and requires iron. Br J Haematol 2002; 117: 727-34.
36. Xaus J, Comalada M, Cardo M, Valledor AF, Celada A. Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27(Kip1) and p21(Waf1). Blood 2001; 98: 2124-33.
37. Asada M, Yamada T, Ichijo H, Miyazono K, Fukumuro K, Mizu- tani S, et al. Apoptosis inhibitory activity of cytoplasmic p21 (Cip1/WAF1) in monocytic differentiation. Embo J 1999; 18: 1223-34.
38. Asada M, Yamada T, Fukumuro K, Mizutani S. p21Cip1/WAF1 is important for differentiation and survival of U937 cells. Leukemia 1998; 12: 1944-50.
39. Rosato RR, Wang Z, Gopalkrishnan RV, Fisher PB, Grant S. Evidence of a functional role for the cyclin-dependent kinase- inhibitor p21WAF1/CIP1/MDA6 in promoting differentiation and preventing mitochondrial dysfunction and apoptosis induced by sodium butyrate in human myelomonocytic leukemia cells (U937). Int J Oncol 2001; 19: 181-91.
40. Gorospe M, Liu Y, Xu Q, Chrest FJ, Holbrook NJ. Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2. Mol Cell Biol 1996; 16: 762-70.
41. Liu M, Iavarone A, Freedman LP. Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J Biol Chem 1996; 271: 31723-8.
42. Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP. Tran- scriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 1996; 10: 142-53.
43. Bellido T, O'Brien CA, Roberson PK, Manolagas SC. Transcrip- tional activation of the p21(WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro- differentiating and anti-apoptotic effects on human osteoblastic cells. J Biol Chem 1998; 273: 21137-44.
44. Datto MB, Yu Y, Wang XF. Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/ p21 promoter. J Biol Chem 1995; 270: 28623-8.
45. Pennington KN, Taylor JA, Bren GD, Paya CV. IkappaB kinase- dependent chronic activation of NF-kappaB is necessary for p21 (WAF1/Cip1) inhibition of differentiation-induced apoptosis of monocytes. Mol Cell Biol 2001; 21: 1930-41.
46. Kawashima T, Murata K, Akira S, Tonozuka Y, Minoshima Y, Feng S, et al. STAT5 induces macrophage differentiation of M1 leukemia cells through activation of IL-6 production mediated by NF-kappaB p65. J Immunol 2001; 167: 3652-60.
47. Rumi MA, Sato H, Ishihara S, Ortega C, Kadowaki Y, Kinoshita Y. Growth inhibition of esophageal squamous carcinoma cells by peroxisome proliferator-activated receptor-gamma ligands, J. Lab. Clin. Med. 140: 17-26.
48. Han C, Demetris AJ, Michalopoulos GK, Zhan Q, Shelhamer JH, Wu T. PPARγamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway. Hepatology 2003; 2002(38): 167-77.
49. Ota K, Ito K, Suzuki T, Saito S, Tamura M, Hayashi S, et al. Per- oxisome proliferator-activated receptor gamma and growth inhibition by its ligands in uterine endometrial carcinoma. Clin Cancer Res 2006; 12: 4200-8.
50. Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, et al. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipo- cyte differentiation. J Clin Invest 1997; 100: 3149-53.
51. Aversa G, Punnonen J, Cocks BG, Holder JC, Smith SA, Sanders L, et al. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J Exp Med 1993; 178: 2213-8.
52. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF. Free in PMC Transforming growth factor beta induces the cyclin- dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 1995; 92: 5545-9.
53. David M, Ford D, Bertoglio J, Maizel AL, Pierre J. Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human ker- atinocytes: involvement of STAT6, ERK and p38 MAPK pathways. Oncogene 2001; 20: 6660-8.
54. Kruse N, Tony HP, Sebald W. Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement. Embo J 1992; 11: 3237-44.
55. Laoukili J, Perret E, Willems T, Minty A, Parthoens E, Houcine O, et al. IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells. J Clin Invest 2001; 108: 1817-24.
56. Heim MH. The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus. JRecept Signal Transduct Res 1999; 19: 75-120.
57. O'Shea JJ, Gadina M, Schreiber RD. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 2002; 109(Suppl.): S 121-31.
58. Kaplan MH, Schindler U, Smiley ST, Grusby MJ. Stat6 is required for mediating responses to IL-4 and for development ofTh2 cells. Immunity1996; 4: 313-9.
59. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Leh- mann JM. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 1995; 83: 813-9.
60. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 1995; 83: 803-12.
61. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM. PPARγamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998; 93: 241-52.
62. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARyamma. Cell 1998; 93: 229-40.
63. Xaus J, Besalduch N, Comalada M, Marcoval J, Pujol R, Mañá J, et al. High expression of p21 Waf1 in sarcoid granulomas: a putative role for long-lasting inflammation. J Leukoc Biol 2003; 74: 295-301.
64. Tomita K, Caramori G, Lim S, Ito K, Hanazawa T, Oates T, et al. Increased p21(CIP1/WAF1) and B cell lymphoma leukemia-x(L) expression and reduced apoptosis in alveolar macrophages from smokers. Am JRespir Crit Care Med 2002; 166: 724-31.